tizanidine has been researched along with Asthenia in 2 studies
tizanidine: RN given refers to parent cpd; structure
tizanidine : 2,1,3-Benzothiadiazole substituted at C-4 by a Delta(1)-imidazolin-2-ylamino group and at C-4 by a chloro group. It is an agonist at alpha2-adrenergic receptor sites.
Asthenia: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henney, HR | 2 |
| Fitzpatrick, A | 1 |
| Stewart, J | 1 |
| Runyan, JD | 1 |
| Shah, J | 1 |
2 trials available for tizanidine and Asthenia
| Article | Year |
|---|---|
Relative bioavailability of tizanidine hydrochloride capsule formulation compared with capsule contents administered in applesauce: a single-dose, open-label, randomized, two-way, crossover study in fasted healthy adult subjects.
Topics: Administration, Oral; Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; A | 2008 |
Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
Topics: Adult; Asthenia; Biological Availability; Capsules; Clonidine; Cross-Over Studies; Dietary Fats; Dos | 2007 |